Medical Aspects of Chemical Warfare (2008) - The Black Vault

More documents

Recommendations

Info

Nerve Agents274. Pellegrini JE, Baker AB, Fontenot DJ, Cardenas AF. The effect of oral pyridostigmine bromide nerve agent prophylaxison return of twitch height in persons receiving succinylcholine. Mil Med. 2000;165:252–255.275. Annas GJ. Changing the consent rules for Desert Storm. N Engl J Med. 1992;326:770–773.276. Nightingale SL. Medicine and war. N Engl J Med. 1992;327:1097–1098.219
Page 3 and 4:
The Coat of Arms1818Medical Departm
Page 5:
Textbooks of Military MedicinePubli
Page 8 and 9:
MEDICAL ASPECTS o fCHEMICAL WARFARE
Page 10 and 11:
ContentsContributorsForeword by The
Page 12 and 13:
ContributorsMICHAEL ADLER, PhDResea
Page 14 and 15:
DONALD M. MAXWELL, MSResearch Chemi
Page 16 and 17:
ForewordThe US military has been co
Page 18 and 19:
PrefaceA significant concern for th
Page 20:
PrologueThe original edition of Med
Page 23 and 24:
xxii
Page 25 and 26:
Medical Aspects of Chemical Warfare
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 178 and 179:
Nerve AgentsChapter 5NERVE AGENTSFR
Page 180 and 181:
Nerve AgentsAbout 10,000 to 30,000
Page 182 and 183:
Nerve Agentsphorofluoridate (DFP) w
Page 184 and 185:
Nerve AgentsFig. 5-2. This schemati
Page 186 and 187:
Nerve AgentsExhibit 5-1 continuedis
Page 188 and 189:
Nerve Agentsactivity but only 15% t
Page 190 and 191:
Nerve AgentsTABLE 5-3CHEMICAL, PHYS
Page 192 and 193: Nerve AgentsTABLE 5-4EFFECTS OF EXP
Page 194 and 195: Nerve Agentsaffecting the other eye
Page 196 and 197: Nerve Agentsmay cause severe rhinor
Page 198 and 199: Nerve Agentsof jerks and tremor.Cen
Page 200 and 201: Nerve Agentsand they were decreased
Page 202 and 203: Nerve Agentsnerve agent toxicity on
Page 204 and 205: Nerve Agentspatient. Decontaminatio
Page 206 and 207: Nerve AgentsFig. 5-5. The Mark I ki
Page 208 and 209: Nerve Agentsadministered intramuscu
Page 210 and 211: Nerve Agentsthat hydroxamine reacti
Page 212 and 213: Nerve AgentsOral administration may
Page 214 and 215: Nerve AgentsTABLE 5-7RECOMMENDED TH
Page 216 and 217: Nerve Agentsimpairment such as whee
Page 218 and 219: Nerve Agentssuboptimal, manner. The
Page 220 and 221: Nerve Agentsthan those who did not.
Page 222 and 223: Nerve Agentssible for binding nerve
Page 224 and 225: Nerve Agentsfor comparison was not
Page 226 and 227: Nerve AgentsTABLE 5-11EFFECTS OF PY
Page 228 and 229: Nerve Agentstivity of smooth muscle
Page 230 and 231: Nerve Agents38. Grob D, Lilienthal
Page 232 and 233: Nerve Agents77. McDonough JH, Shih
Page 234 and 235: Nerve Agents117. McLeod CG Jr, Sing
Page 236 and 237: Nerve Agents154. Tryphonas l, Veino
Page 238 and 239: Nerve Agents193. Funckes AJ. Treatm
Page 240 and 241: Nerve Agents235. Suzuki T, Morita H
Page 244 and 245: Neuroprotection as a Treatment for
Page 266 and 267: Nerve Agent Bioscavenger: Developme
Page 282 and 283: VesicantsChapter 8VESICANTSCharles
Page 284 and 285: Vesicantscertain neoplasms. 5-8 In
Page 286 and 287: Vesicantsmonograph by Jan L Willems
Page 288 and 289: Vesicantsand other inhibitors of PA
Page 290 and 291: Vesicantsmainly by the time needed
Page 292 and 293:
VesicantsabcdFig. 8-6. Transient hy
Page 294 and 295:
Vesicantstions with margination, di
Page 296 and 297:
Vesicantsdirectly by the alkylating
Page 298 and 299:
Vesicantsdropped into the eyes of r
Page 300 and 301:
Vesicantsdiagnosis. Friction, plant
Page 302 and 303:
Vesicantsinfusion rates and formula
Page 304 and 305:
Vesicantsactivity against a broad s
Page 306 and 307:
Vesicantsries because of the unique
Page 308 and 309:
Vesicantsdebridement, albeit more t
Page 310 and 311:
Vesicantsresurfacing, dermabrasion,
Page 312 and 313:
VesicantsabcFig. 8-14. (a) Bronchos
Page 314 and 315:
Vesicantstion without significant t
Page 316 and 317:
Vesicants• the inflammatory react
Page 318 and 319:
VesicantsClinical EffectsPhosgene o
Page 320 and 321:
Vesicants25. Aitken RS. Effects of
Page 322 and 323:
Vesicants64. Momeni A, Enshaeih S,
Page 324 and 325:
Vesicants101. Marshall EK Jr. Physi
Page 326 and 327:
Vesicants141. Barillo DJ, McManus A
Page 328 and 329:
Vesicants179. Eldad A, Weinberg A,
Page 330 and 331:
Vesicants219. Rheinwald JG, Green H
Page 332 and 333:
Vesicants260. Prandtl W, Sennewald
Page 334 and 335:
Long-Term Health Effects of Chemica
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Toxic Inhalational Injury and Toxic
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
PROCESSToxic Inhalational Injury an
Page 380 and 381:
PROCESSToxic Inhalational Injury an
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Cyanide PoisoningChapter 11CYANIDE
Page 396 and 397:
Cyanide Poisoningas “the cherry d
Page 398 and 399:
Cyanide PoisoningFig. 11-1. Likely
Page 400 and 401:
Cyanide PoisoningToxicityAlthough g
Page 402 and 403:
Cyanide PoisoningTable 11-2 continu
Page 404 and 405:
Cyanide PoisoningTABLE 11-3Endogeno
Page 406 and 407:
Cyanide Poisoningcyanide may cause
Page 408 and 409:
Cyanide PoisoningHCNCCOHbO 2MetHbHC
Page 410 and 411:
Cyanide Poisoningcyanide has been i
Page 412 and 413:
Cyanide Poisoningputed tomography s
Page 414 and 415:
Cyanide PoisoningDose (mg/kg)16.014
Page 416 and 417:
Cyanide PoisoningVoltage (mV)40200-
Page 418 and 419:
Cyanide PoisoningTable 11-5Antidote
Page 420 and 421:
Cyanide Poisoningbitol, and other B
Page 422 and 423:
Cyanide Poisoning23. Knight AP, Wal
Page 424 and 425:
Cyanide Poisoning64. Paulet G, Char
Page 426 and 427:
Cyanide Poisoning106. Goenechea S.
Page 428 and 429:
Cyanide Poisoning145. Mégarbane B,
Page 430 and 431:
Cyanide Poisoning187. Bucaretchi F,
Page 432 and 433:
Cyanide Poisoning226. Chen KK, Rose
Page 434 and 435:
Incapacitating AgentsChapter 12INCA
Page 436 and 437:
Incapacitating Agentsdrugged wine,
Page 438 and 439:
Incapacitating Agentstheir impact.
Page 440 and 441:
Incapacitating Agentsout a series o
Page 442 and 443:
Incapacitating Agentsthis chapter.D
Page 444 and 445:
Incapacitating Agents“Biotechnolo
Page 446 and 447:
Incapacitating Agentsconditions and
Page 448 and 449:
Incapacitating AgentsSeveral other
Page 450 and 451:
Incapacitating AgentsSafety of the
Page 452 and 453:
Incapacitating AgentsTABLE 12-1DIFF
Page 454 and 455:
Incapacitating AgentsNonLethal Weap
Page 456 and 457:
Incapacitating Agents7. Gaultier M,
Page 458 and 459:
Incapacitating Agents47. Buckman J.
Page 460 and 461:
Incapacitating Agents87. Chen Y, Da
Page 462 and 463:
Incapacitating Agents126. Sidell FR
Page 464 and 465:
Riot Control AgentsChapter 13Riot C
Page 466 and 467:
Riot Control AgentsPolice departmen
Page 468 and 469:
Riot Control AgentsTable 13-1CHARAC
Page 470 and 471:
Riot Control Agentsal 27 reported t
Page 472 and 473:
Riot Control Agentsoxygen from the
Page 474 and 475:
Riot Control Agentscaused the CS to
Page 476 and 477:
Riot Control Agentsnumerous factors
Page 478 and 479:
Riot Control Agentsexposure. In hum
Page 480 and 481:
Riot Control Agentsrespiration (RD
Page 482 and 483:
Riot Control AgentsTable 13-3 conti
Page 484 and 485:
Riot Control Agentsand increased li
Page 486 and 487:
Riot Control AgentsCN for years. In
Page 488 and 489:
Riot Control AgentsClinical Effects
Page 490 and 491:
Riot Control AgentsCR (Dibenz(b,f)(
Page 492 and 493:
Riot Control Agentsability and that
Page 494 and 495:
Riot Control AgentsNC); or Cool It!
Page 496 and 497:
Riot Control Agentswithout adequate
Page 498 and 499:
Riot Control Agents36. Thomas RJ, S
Page 500 and 501:
Riot Control Agents73. Olajos EJ, S
Page 502 and 503:
Riot Control Agents112. Centers for
Page 504 and 505:
Riot Control Agents153. Owens EJ, M
Page 506 and 507:
Riot Control Agents189. Carter, RH,
Page 508 and 509:
Field Management of Chemical Casual
Page 510 and 511:
Page 512 and 513:
Page 514 and 515:
Page 516 and 517:
Page 518 and 519:
Page 520 and 521:
Page 522 and 523:
Page 524 and 525:
Page 526 and 527:
Page 528 and 529:
Page 530 and 531:
Page 532:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557 and 558:
Page 559 and 560:
Page 561 and 562:
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 582 and 583:
Chemical Defense EquipmentChapter 1
Page 584 and 585:
Chemical Defense EquipmentINDIVIDUA
Page 586 and 587:
Chemical Defense EquipmentThe faceb
Page 588 and 589:
Chemical Defense Equipmentquantitat
Page 590 and 591:
Chemical Defense EquipmentabFig. 17
Page 592 and 593:
Chemical Defense Equipmentabjoint s
Page 594 and 595:
Chemical Defense EquipmentExhibit 1
Page 596 and 597:
Chemical Defense Equipmentworn for
Page 598 and 599:
Chemical Defense EquipmentPsycholog
Page 600 and 601:
Page 602 and 603:
Page 604 and 605:
Chemical Defense Equipmentgerous ch
Page 606 and 607:
Chemical Defense Equipmenttuses pre
Page 608 and 609:
Chemical Defense Equipmentcollectiv
Page 610 and 611:
Page 612 and 613:
Chemical Defense Equipmentdecontami
Page 614 and 615:
Chemical Defense Equipment22. Depar
Page 616 and 617:
Occupational Health and the Chemica
Page 618 and 619:
Page 620 and 621:
Page 622 and 623:
Page 624 and 625:
Page 626 and 627:
Page 628 and 629:
Page 630 and 631:
Page 632 and 633:
Page 634 and 635:
Page 636 and 637:
Toxins: Established and Emergent Th
Page 638 and 639:
Page 640 and 641:
Page 642 and 643:
Page 644 and 645:
Page 646 and 647:
Page 648 and 649:
Page 650 and 651:
Page 652 and 653:
Page 654 and 655:
Page 656 and 657:
Page 658 and 659:
Page 660 and 661:
Page 662 and 663:
Page 664 and 665:
Page 666 and 667:
Page 668 and 669:
Medical Chemical Defense Acquisitio
Page 670 and 671:
Page 672 and 673:
Page 674 and 675:
Page 676 and 677:
Page 678 and 679:
Medical Management of Chemical Toxi
Page 680 and 681:
Page 682 and 683:
Page 684 and 685:
Page 686 and 687:
Page 688 and 689:
Page 690 and 691:
Page 692 and 693:
Page 694 and 695:
Page 696 and 697:
Page 698 and 699:
Page 700 and 701:
Page 702 and 703:
Page 704 and 705:
Page 706 and 707:
Page 708 and 709:
Page 710 and 711:
Page 712 and 713:
Page 714 and 715:
Medical DiagnosticsChapter 22MEDICA
Page 716 and 717:
Medical Diagnosticsdifficult to int
Page 718 and 719:
Medical Diagnosticshalf-life rates
Page 720 and 721:
Medical DiagnosticsTable 22-1Analyt
Page 722 and 723:
Medical Diagnosticsplus the parent
Page 724 and 725:
Medical Diagnosticsas soman. Few me
Page 726 and 727:
Medical DiagnosticsHuman blood coll
Page 728 and 729:
Medical DiagnosticsTable 22-5Red Bl
Page 730 and 731:
Medical Diagnosticsrecently, a larg
Page 732 and 733:
Medical Diagnosticsof deuterated TD
Page 734 and 735:
Medical DiagnosticsTable 22-8Target
Page 736 and 737:
Medical DiagnosticsLC-MS-MS method
Page 738 and 739:
Medical DiagnosticsTable 22-9 conti
Page 740 and 741:
Medical Diagnosticsmonosulfoxide MS
Page 742 and 743:
Medical Diagnosticsisolation of the
Page 744 and 745:
Medical DiagnosticsabcOCH 2CH 2SCH
Page 746 and 747:
Medical DiagnosticsabcglobinSOCglob
Page 748 and 749:
Medical DiagnosticsExhibit 22-3 con
Page 750 and 751:
Medical DiagnosticsTable 22-12Publi
Page 752 and 753:
Medical DiagnosticsClHAsCCClClHaH 2
Page 754 and 755:
Medical Diagnosticsurine samples. T
Page 756 and 757:
Medical DiagnosticsTable 22-13 cont
Page 758 and 759:
Medical DiagnosticsThe estimated LC
Page 760 and 761:
Medical Diagnosticsstudy of chlorof
Page 762 and 763:
Medical DiagnosticsNOOCCOH(Figure 2
Page 764 and 765:
Medical DiagnosticsStorageUpon arri
Page 766 and 767:
Medical Diagnostics25. Noort D, Hul
Page 768 and 769:
Medical Diagnostics63. EQM Research
Page 770 and 771:
Medical Diagnostics99. Sandelowsky
Page 772 and 773:
Medical Diagnostics136. Izraeli S,
Page 774 and 775:
Medical Diagnostics181. Guastadiseg
Page 776 and 777:
Domestic PreparednessChapter 23Dome
Page 778 and 779:
Domestic Preparednessefforts led to
Page 780 and 781:
Domestic PreparednessaIncidentComma
Page 782 and 783:
Domestic PreparednessNIMS Framework
Page 784 and 785:
Domestic Preparednessmost likely be
Page 786 and 787:
Domestic Preparedness17 corpsmen. A
Page 788 and 789:
Domestic PreparednessNational Prepa
Page 790 and 791:
Domestic Preparednessdiation and re
Page 792 and 793:
Domestic Preparednesstreatment, and
Page 794 and 795:
Domestic Preparedness7. US Office o
Page 796:
Domestic Preparedness47. Federal Em
Page 799 and 800:
Page 802 and 803:
IndexIndexAAberdeen Biological Chem
Page 804 and 805:
Indexchlorine gas attack and, 66Aum
Page 806 and 807:
Indexbioscavenger use, 245, 706desc
Page 808 and 809:
Indexpsychological effect of, 2, 19
Page 810 and 811:
IndexZyklon B development, 15Cyanid
Page 812 and 813:
Indexpackaging specimens, 740phosge
Page 814 and 815:
Indexassignment of specific emergen
Page 816 and 817:
Indexsoman-induced seizure-related
Page 818 and 819:
Indexlegal barriers to acceptance a
Page 820 and 821:
IndexKKargin, Col. V.A.capture of s
Page 822 and 823:
Indexdescription and uses, 566M40A1
Page 824 and 825:
Indextive liner systemdescription a
Page 826 and 827:
Indexeffects of exposure to nerve a
Page 828 and 829:
IndexOccupational Safety and Health
Page 830 and 831:
IndexPersian Gulf War. See also Ope
Page 832 and 833:
Index704red blood cell and acetylch
Page 834 and 835:
IndexShaw, F.H.organophosphate inse
Page 836 and 837:
Indexseizure-related brain damage a
Page 838 and 839:
IndexTreatment of nerve agent expos
Page 840 and 841:
Indexevacuation hospitals, 94-95eva
Page 842 and 843:
IndexT-shell development, 14VR nerv
Page 844 and 845:
Dedicated to the Memory ofBrennie E
show all

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Create successful ePaper yourself

Delete template?

Save as template?